EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A bidirectional autoimmune cluster between vitiligo and rheumatoid arthritis: a large-scale population-based study

Naama Tova Cohen, Yochai Schonmann, Khalaf Kridin

Archives of Dermatological Research · 2024

DOI: 10.1007/s00403-024-02965-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Dermatological Research, 2024. Verfasst von Naama Tova Cohen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel. Hauptthemen laut MEDLINE: Vitiligo, Arthritis, Rheumatoid. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bar-Ilan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A knowledge gap exists regarding the association between vitiligo and rheumatoid arthritis (RA) due to the absence of large-scale cohort studies designed to investigate this association. To investigate the bidirectional epidemiological association between vitiligo and RA. A population-based study was conducted using Clalit Health Services (CHS) database (2002–2019) using both a cohort study and a case-control study design. Adjusted hazard ratio (HR) and odds ratio (OR) were calculated by multivariate Cox and logistic regressions, respectively. Overall, 20,851 vitiligo patients and 102,475 controls were included. The incidence of new-onset RA was 4.1 (95% CI 3.0–5.4) and 2.9 (95% CI 2.4–3.3) cases per 10,000 person-years among patients with vitiligo and controls, respectively. Patients with vitiligo had a significantly increased risk of developing new-onset RA (adjusted HR, 1.44; 95% confidence interval [CI], 1.02–2.02, P = 0.036). The likelihood of having vitiligo was significantly elevated after a preexisting diagnosis of RA (adjusted OR, 1.67; 95% CI, 1.38–2.03; P < 0.001). Relative to the remaining patients with vitiligo, those with vitiligo and comorbid RA demonstrated an elevated risk of all-cause mortality (adjusted HR, 1.61; 95% CI, 1.03–2.51; P = 0.037). Our study confirms the bidirectional association between vitiligo and RA. Physicians treating patients with vitiligo should be aware of the association in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VitiligoArthritis, RheumatoidHumansFemaleMaleMiddle AgedCase-Control StudiesAdultIncidenceAgedTaiwanRisk FactorsDatabases, Factual

Stichwörter der Autor:innen

Case-control studyCohort studyRheumatoid arthritisVitiligo

Autor:innen und Institutionen

  • Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
  • Medical School for International Health, Ben Gurion University, Negev Be'er Sheva, Israel.
  • Clalit Health Services, Tel-Aviv, Israel.
  • Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel. dr_kridin@hotmail.com.
  • Clalit Health Services, Tel-Aviv, Israel. dr_kridin@hotmail.com.
  • Unit of Dermatology and Skin Research Laboratory, Galilee Medical Center, Nahariya, Israel. dr_kridin@hotmail.com.

Förderung

  • Bar-Ilan University

Zitieren

APA

Cohen, N. T., Schonmann, Y., & Kridin, K. (2024). A bidirectional autoimmune cluster between vitiligo and rheumatoid arthritis: a large-scale population-based study. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-02965-7

Vancouver

Cohen NT, Schonmann Y, Kridin K. A bidirectional autoimmune cluster between vitiligo and rheumatoid arthritis: a large-scale population-based study. Archives of Dermatological Research. 2024. doi:10.1007/s00403-024-02965-7

BibTeX
@article{Cohen2024,
  author = {Cohen, Naama Tova and Schonmann, Yochai and Kridin, Khalaf},
  title = {A bidirectional autoimmune cluster between vitiligo and rheumatoid arthritis: a large-scale population-based study},
  journal = {Archives of Dermatological Research},
  year = {2024},
  doi = {10.1007/s00403-024-02965-7}
}
Kostenlos starten →